APA (7th ed.) Citation

M, G., T, N., D, M., G, I., M, N., K, B., . . . H, S. (2026). Clinical utility of the ESTRO-EORTC classification in oligometastatic disease treated with stereotactic body radiotherapy: A single-institution retrospective study. Clinical & experimental metastasis, 43(2), . https://doi.org/10.1007/s10585-026-10398-x

Chicago Style (17th ed.) Citation

M, Goto, Nonaka T, Maruyama D, Ishii G, Nakamura M, Baba K, Nitta H, and Sakurai H. "Clinical Utility of the ESTRO-EORTC Classification in Oligometastatic Disease Treated with Stereotactic Body Radiotherapy: A Single-institution Retrospective Study." Clinical & Experimental Metastasis 43, no. 2 (2026). https://doi.org/10.1007/s10585-026-10398-x.

MLA (9th ed.) Citation

M, Goto, et al. "Clinical Utility of the ESTRO-EORTC Classification in Oligometastatic Disease Treated with Stereotactic Body Radiotherapy: A Single-institution Retrospective Study." Clinical & Experimental Metastasis, vol. 43, no. 2, 2026, https://doi.org/10.1007/s10585-026-10398-x.